NCI-J; : june 20-21, 2019; DR. Tushar DEB; bethesda north marriott hotel & conference center; total hotel cost complies with HHS policy on promoting efficient spending as of 1/3/2012
Ended Awarded Last action
- Contract number
- 75N91019F00137
- Awardee
-
Bsrep II MBN LLC UEI TRP2FSD3MF43
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,107
Award facts
- Contract value 100% obligated
- $17,107.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 721110 Hotels (except Casino Hotels) and Motels
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Bethesda, MD 20852, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$4,478 | |
| Original award | $21,585 |
About this award
The National Cancer Institute (NCI) awarded a Blanket Purchase Agreement (BPA) call to Bsrep II MBN LLC, doing business as Bethesda North Marriott Hotel & Conference Center, for $17,107.25 under a firm fixed-price contract type. The award, dated June 20, 2019, with an ultimate completion date of March 25, 2024, was executed to support the NCI-J conference held June 20-21, 2019, at the Bethesda North Marriott Hotel & Conference Center in Bethesda, Maryland. The contract encompassed hospitality services including conference space, lodging, and related facilities for the event. No set-aside designation was utilized for this award, indicating the contractor competed on a standard competitive basis.
Bsrep II MBN LLC is a subsidiary of Marriott International, Inc., and a registered SAM.gov entity specializing in hospitality services for federal agencies. The company has an established track record supporting NIH institutes and other federal organizations with conference and meeting services. A subsequent de-obligation action was processed in December 2023 to de-obligate FY2019 expiring funds from this line in accordance with NIH Office of Administrative and Management Services (OALM) communication 24-16. The hotel cost complied with HHS policy on efficient spending as of January 3, 2012.
Quick answers
Who was awarded contract 75N91019F00137?
75N91019F00137 was awarded to Bsrep II MBN LLC by National Cancer Institute (National Institutes of Health) on June 20, 2019.
How much is contract 75N91019F00137 worth?
The government has obligated $17,107 on 75N91019F00137.
Is contract 75N91019F00137 an order under another contract?
Yes. 75N91019F00137 is a BPA call under HHSN263201500186B, a blanket purchase agreement.
Was contract 75N91019F00137 competed?
The extent of competition for 75N91019F00137 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award